| Autor: |
Wade, Emma M., Morgan, Tim, Gimenez, Gregory, Jenkins, Zandra A., Titheradge, Hannah, O'Donnell, Marie, Skidmore, David, Suri, Mohnish, Robertson, Stephen P. |
| Zdroj: |
American Journal of Medical Genetics. Part A; Oct2024, Vol. 194 Issue 10, p1-9, 9p |
| Abstrakt: |
Pathogenic variants in FLNA cause a diversity of X‐linked developmental disorders associated with either preserved or diminished levels of filamin A protein and are conceptualized dichotomously as relating to underlying gain‐ or loss‐of‐function pathogenic mechanisms. Hemizygosity for germline deletions or truncating variants in FLNA is generally considered to result in embryonic lethality. Structurally, filamin A is composed of an N‐terminal actin‐binding region, followed by 24 immunoglobulin‐like repeat units. The repeat domains are separated into distinct segments by two regions of low‐complexity known as hinge‐1 and hinge‐2. Hinge‐1 is proposed to confer flexibility to the otherwise rigid protein and is a target for cleavage by calpain with the resultant filamin fragments mediating crucial cellular signaling processes. Here, three families with pathogenic variants in FLNA that impair the function of hinge‐1 in males are described, leading to distinct clinical phenotypes. One large in‐frame deletion that includes the hinge leads to frontometaphyseal dysplasia in affected males and females, while two germline truncating variants located within the exon encoding hinge 1 result in phenotypes in males that are explained by exon skipping and under‐expression of a transcript that deletes hinge‐1 from the resultant protein. These three variants affecting hinge‐1 indicate that this domain does not mediate cellular functions that, when deficientresult in embryonic lethality in males and that germline truncating variants in this region of FLNA can result in viable phenotypes in males. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text